Statistics for Nuo Therapeutics, (id:11263 AURX)

Valuation metrics

Market cap

50.79M

Enterprise value

50.12M

Trailing P/E (ttm)

-13.62

Forward P/E

PEG ratio

Price/Sales (ttm)

83.47

Price/Book (mrq)

47.39

Enterprise Value/Revenue

82.36

Enterprise Value/EBITDA

-16.36

Overview

Shares outstanding

46.60M

Float

19.21M

Shares short

% Held by insiders

0.58%

% Held by institutions

0.05%

Average volume (10 days)

4.58K

Average volume (90 days)

Price summary

52-Week low

0.25

52-Week high

1.27

52-Week change

55.96%

Beta

-740.14

50-Day moving average

0.66

200-Day moving average

0.66

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

79.28%

Operating margin

-520.65%

Operational effectiveness

Return on assets

-168.88%

Return on equity

-305.20%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

482.43K

EBITDA

0.00

Net income to common (ttm)

-3,171,436.00

Diluted EPS (ttm)

-0.06

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

0.00

Total cash per share (mrq)

0.01

Total debt (mrq)

179.31K

Total Debt/Equity (mrq)

0.20

Current ratio (mrq)

188.05%

Book value per share (mrq)

0.02

Cash flow

Cash flow statement

-3,431,110.00

Levered free cash flow (LFCF)

-3,171,436.00